Search

everythinglearnresearchcommunity

for

Search:↓

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

PDRN helps repair tissue and improve wound healing with a high safety profile.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

RXR agonists may promote hair growth in humans.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

17β-estradiol may help hair growth by increasing cannabinoid receptor type 1.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Promising cancer treatments were found, but the manufacturer closed.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.